Immedica Pharma AB /
Marinus Pharmaceuticals, Inc.
Immedica completes acquisition of Marinus Pharmaceuticals, Inc.




What happened
Immedica Pharma AB completed its acquisition of Marinus Pharmaceuticals, Inc. on Feb. 11, 2025, through its indirect wholly owned subsidiary Matador Subsidiary, Inc. Marinus became an indirect wholly owned subsidiary of Immedica.
The aggregate consideration was approximately $32.3 million, excluding related transaction fees and expenses.
The source
Everything on this page comes from the source below.
Immedica completes acquisition of Marinus Pharmaceuticals, Inc.
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Source-verifiedPublished by the source
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly